Paper2155708
Elevated levels of the alpha 5 beta 1 fibronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells.
Giancotti FG and 1 other. Cell, 1990. Cited by 805 papers, by iCite.
Cite this record
ConductScience Library. Elevated levels of the alpha 5 beta 1 fibronectin receptor suppress the transformed phenotype of Chinese hamster ovary cells. Papers, record 2155708. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/2155708
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics22
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Cell Transformation, Neoplastic | Major topic |
| Integrins | Major topic |
| Receptors, Immunologic | Major topic |
| Transfection | Major topic |
| Animals | |
| Cell Adhesion | |
| Cell Division | |
| Cell Line | |
| Cell Movement | |
| Cricetinae | |
| Cricetulus | |
| Female | |
| Fibronectins | |
| Gene Amplification | |
| Gene Expression | |
| Genetic Vectors | |
| Humans | |
| Macromolecular Substances | |
| Ovary | |
| Phenotype | |
| Receptors, Fibronectin | |
| Simian virus 40 |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA 28896 | NCI NIH HHS | United States | P01CA028896 | PubMed and NIH | NIH RePORTER |
| CA 30199 | NCI NIH HHS | United States | P30CA030199 | PubMed and NIH | NIH RePORTER |
| CA 42507 | NCI NIH HHS | United States | R35CA042507 | PubMed and NIH | NIH RePORTER |
Cited by213
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 805 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42787254 | Beyond Structure: The Dynamic Role of the Extracellular Matrix Components in Immune Evasion. | Cancer Commun (Lond) | 2026 | https://conductscience.org/library/papers/42787254 | PubMed |
| 40083943 | Unveiling the potential of biomechanics in pioneering innovative strategies for cancer therapy. | Theranostics | 2025 | https://conductscience.org/library/papers/40083943 | PubMed |
| 37296983 | Awakening of Dormant Breast Cancer Cells in the Bone Marrow. | Cancers (Basel) | 2023 | https://conductscience.org/library/papers/37296983 | PubMed |
| 35884405 | Stromal Co-Cultivation for Modeling Breast Cancer Dormancy in the Bone Marrow. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/35884405 | PubMed |
| 34661072 | Selective Integrin Ligands Promote Cell Internalization of the Antineoplastic Agent Fluorouracil. | ACS Pharmacol Transl Sci | 2021 | https://conductscience.org/library/papers/34661072 | PubMed |
| 32366988 | Side chain effect in the modulation of αvβ3/α5β1 integrin activity via clickable isoxazoline-RGD-mimetics: development of molecular delivery systems. | Sci Rep | 2020 | https://conductscience.org/library/papers/32366988 | PubMed |
| 32004443 | Basement Membrane Regulates Fibronectin Organization Using Sliding Focal Adhesions Driven by a Contractile Winch. | Dev Cell | 2020 | https://conductscience.org/library/papers/32004443 | PubMed |
| 31861892 | Fibronectin in Cancer: Friend or Foe. | Cells | 2019 | https://conductscience.org/library/papers/31861892 | PubMed |
| 30889378 | Integrin Signaling in Cancer: Mechanotransduction, Stemness, Epithelial Plasticity, and Therapeutic Resistance. | Cancer Cell | 2019 | https://conductscience.org/library/papers/30889378 | PubMed |
| 30206629 | Computational model of wound healing: EGF secreted by fibroblasts promotes delayed re-epithelialization of epithelial keratinocytes. | Integr Biol (Camb) | 2018 | https://conductscience.org/library/papers/30206629 | PubMed |
| 28552962 | Retinoic acid receptor gamma impacts cellular adhesion, Alpha5Beta1 integrin expression and proliferation in K562 cells. | PLoS One | 2017 | https://conductscience.org/library/papers/28552962 | PubMed |
| 28106780 | Integrins and Cell Metabolism: An Intimate Relationship Impacting Cancer. | Int J Mol Sci | 2017 | https://conductscience.org/library/papers/28106780 | PubMed |
| 27680681 | α3β1 Integrin Suppresses Prostate Cancer Metastasis via Regulation of the Hippo Pathway. | Cancer Res | 2016 | https://conductscience.org/library/papers/27680681 | PubMed |
| 26702126 | Intravenous Administration of Endothelial Colony-Forming Cells Overexpressing Integrin β1 Augments Angiogenesis in Ischemic Legs. | Stem Cells Transl Med | 2016 | https://conductscience.org/library/papers/26702126 | PubMed |
| 26483551 | Integrin α5 Suppresses the Phosphorylation of Epidermal Growth Factor Receptor and Its Cellular Signaling of Cell Proliferation via N-Glycosylation. | J Biol Chem | 2015 | https://conductscience.org/library/papers/26483551 | PubMed |
| 25189355 | RSK promotes prostate cancer progression in bone through ING3, CKAP2, and PTK6-mediated cell survival. | Mol Cancer Res | 2015 | https://conductscience.org/library/papers/25189355 | PubMed |
| 24808173 | Tenascin-C-derived peptide TNIIIA2 highly enhances cell survival and platelet-derived growth factor (PDGF)-dependent cell proliferation through potentiated and sustained activation of integrin α5β1. | J Biol Chem | 2014 | https://conductscience.org/library/papers/24808173 | PubMed |
| 24089214 | Geometric control of cell migration. | Sci Rep | 2013 | https://conductscience.org/library/papers/24089214 | PubMed |
| 23917679 | Heparin-binding EGF-like growth factor enhances the activity of invasion and metastasis in thyroid cancer cells. | Oncol Rep | 2013 | https://conductscience.org/library/papers/23917679 | PubMed |
| 22410175 | Endothelial progenitor cells and integrins: adhesive needs. | Fibrogenesis Tissue Repair | 2012 | https://conductscience.org/library/papers/22410175 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| FN1 | 2335 | PubTator's text mining | https://conductscience.org/library/genes/2335 | NCBI Gene |
| IGKV2D-26 | 28884 | PubTator's text mining | https://conductscience.org/library/genes/28884 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/2155708
GET https://conductscience.org/api/papers/v1/2155708/cited_by?page=2